Corneal graft survival and intraocular pressure control after Descemet stripping automated endothelial keratoplasty in eyes with pre-existing glaucoma.

Slides:



Advertisements
Similar presentations
Therapeutic Penetrating Keratoplasty in Fungal Keratitis: Prospective Study Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Advertisements

Sérgio Kwitko, Tiago Lansini, Andressa P Stolz, Diane R Marinho Authors have no financial interest in the subject matter of this poster.
Venting Incisions in DSAEK Patients: Is It an Absolute Necessity?
Use of a Novel Y- Suture Technique to Reduce Detachments in Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) Habeeb Ahmad, MD Martin Heur,
The authors have no financial interests to disclose
Retrospective comparison of staged versus combined cataract surgery and Descemet’s-stripping endothelial keratoplasty (DSEK) in patients with Fuchs’ Dystrophy.
Early Outcomes of Descemet’s Stripping Automated Endothelial Keratoplasty in Pseudophakic Eyes with Anterior Chamber Intraocular Lenses Preeya K. Gupta.
Roy E Lehman MD*, Samuel F Fulcher MD**
Relationship Between Donor Graft Cell Count and Visual Outcome in DSAEK Patients Authors Silvin Bakalian MD PhD, Johanna Choremis MD FRCSC, Michele Mabon.
Jeffrey J. Ing, MD, FACS, (Delta Eye Medical Group, Loma Linda University School of Medicine, Department of Ophthalmology) Thanh T. Nguyen, OD (Delta Eye.
DSAEK in Eyes With Severe Pre-operative Visual Acuity Loss. 1. Sightline Ophthalmic Associates, Pittsburgh, PA 2. Devers Eye Institute, Portland, OR 3.
Dislocation of the DSEK Donor Graft into the Posterior Segment An Intraoperative Complication in DSEK Surgery Mark M Fernandez MD, Mark S Gorovoy MD, George.
Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,
Boston Type I Keratoprosthesis and Silicone Oil for the Treatment of Hypotony in Prephthisis Kristiana D. Neff 1, William I. Sawyer 2, Michael R. Petersen.
The Diabetic Retinopathy Clinical Research Network Repeated Intravitreous Ranibizumab Injections for DME and Risk of Sustained IOP Elevation or Need for.
The Effect of the Restor Multifocal IOL on Frequency Doubling Perimetry Elizabeth Yeu, MD1, Elizabeth Woznak, BS2, Nicole Kesten, BS2, Steven VL Brown,
Bryan Y Kim 1, Shintaro Kanayama MD PhD 1, Tueng T Shen MD PhD 1, Thomas E Gillette MD 2 1 University of Washington Department of Ophthalmology, 2 Eye.
Somasheila I. Murthy, Prashant Garg, Pravin K. Vaddavalli
Will my Glaucoma patient lose vision ?
Purpose: Introduction:  At initial evaluation: For post-op day # 0 patients: Pre-op VA was 20/50.6 (0.395 ± 0.198); Post-op VA was 20/102.0 (0.196 ± 0.162);
OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew.
Urrets-Zavalia Syndrome Following Descemet Stripping Endothelial Keratoplasty Claire Y. Chu, MD Pawan Prasher, MD Eric Dai, MD R. Wayne Bowman, MD V. Vinod.
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice Hugo Y. Hsu and Sean L. Edelstein The authors have no financial interest.
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
Case Report of Severe Haze After DSAEK
Indications for and Outcomes of Therapeutic Penetrating Keratoplasty Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author has no.
Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting.
AlphaCor TM : A Novel Approach to Minimize Late Post-operative Complications V. Ngakeng MD, M. Price PhD. MBA, F. Price MD.
Combined Phacoemulsification and Ahmed Glaucoma Drainage Implant Surgery Leonidas Traipe, M.D. Felipe Valenzuela, M.D. Carlos Nieme, M.D Juan Stoppel,
1 Clinical Outcomes of DSEK Surgery Combined With Other Intraocular Procedures Neil Mahesh Vyas, MD Fei Yu, PhD Anthony J. Aldave, MD Sophie Deng, MD,
Endothelial Keratoplasty in Patients With an Anterior Chamber Intraocular Lens: A Montreal Experience Georges M. Durr, MD 1,2 Johanna Choremis, MD, FRCSC.
Clinical outcome of DALK in Keratoconus – A one year follow up
E-Poster Price Vision Group & Cornea Research Foundation of America Descemet - Stripping Endothelial Keratoplasty :Survival Outcomes in Eyes with Pre-
Mean Keratometry Measurement Post Penetrating Keratoplasty Jacky Yeung MSc MD, Stephanie Baxter MD FRCS(C) Department of Ophthalmology, Hotel Dieu Hospital,
Descemet Stripping Automated Endothelial Keratoplasty with a Graft Insertion Device : Technique and Early Results Dr Wei-Boon KHOR, MRCS(Ed), Dr Jodhbir.
Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,
J. Brian Foster, MD No Financial Disclosures
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
Zonular Weakness in Patients with Primary Angle-Closure Glaucoma Yong Yeon Kim 1, Keny Kirti 2, Bokun Rho 1 Department of Ophthalmology, Korea University.
Daniel D. Hayes, MD1; Carolyn Y. Shih, MD1; David C
Risk Factors and Outcomes of Donor Lenticule Dislocation Following DSEK Pravin K Vaddavalli MD, Suntia Chaurasia MD, Muralidhar Ramappa MD, Prashant Garg.
Efficacy and Safety of the Ex-PRESS Glaucoma Mini-Shunt with Intraoperative 5-Fluorouracil ASCRS 2009 – San Francisco A. Balashanmugam, MD, L. Farrokh-Siar,
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
Jodhbir S Mehta, Donald Tan The Authors have a financial Interest in the Endoglide patent/royalty.
Etiological and decision making factors for repeat DSAEK or PK in cases of failed Descemet stripping automated endothelial keratoplasty First and Presenting.
DSEK for the treatment of endothelial disease in India -Initial Experience in 80 eyes- Authors have no financial interest Dr Ashish Nagpal MD, FRCS Dr.
Post-Operative Management of Vitreous Adhesion after DSAEK with YAG Laser Vitreolysis Sherif Idris 1, Ahmed Al-Ghoul 2 MD FRCSC DipABO 1 University of.
Descemet’s stripping automated endothelial keratoplasty by novice endothelial keratoplasty surgeons Jason W. Much, M.D. 1 Paul M. Phillips, M.D. 1,2 Leslie.
Descemet’s Stripping Endothelial Keratoplasty (DSEK) in patients with prior Trabeculectomy or Tube shunt surgery. Thadani S.M. Fynn-Thompson N. Authors.
Effect of Donor Processing and Storage Time and Preoperative Endothelial Cell Counts on DSAEK Detachment Rates Daniel Demsey BScE Stephanie Baxter MD,
iStent with phacoemulsification, n=50
Tulsi Changulani 1,*, Jenny Bo 2, Mei-Ling Cheng 1, Andrew Tatham 1
IOP control and corneal endothelial cell density changes
Outcomes of Descemet Stripping Automated Endothelial Keratoplasty in patients with a Pre-Existing Anterior Chamber Intraocular Lens S. Elderkin1A, E. Tu1A,
B. Kozomara, E. Potkonjak, R. Lazic, N. Gabric
Outcomes and Complications of DSEK in Eyes with Tube shunts or ACIOLs
Endothelial keratoplasty in failed grafts
Kyoto Prefectural University of Medicine
Early Experience with Descemet’s Stripping Automated Endothelial Keratoplasty Combined with Phacoemulsification: Clinical and Refractive Outcome University.
Hong A, Boehlke CS, Afshari NA, Kim T Duke University Medical Center
No Financial Interest in Study Material
Long term Results of Endothelial Keratoplasty in patients with failed penetrating Keratoplasty Maoz D. Amiran, MD, Raneen Shehadeh-Mashor, MD, Marie Eve.
Clinical study of open angle glaucoma surgery treatment trough deep slerectomy with T-Flux NV implant: three years follow-up Dr. Marco Rossi Dr Michele.
Glaucoma Progression after Descemet’s Stripping Endothelial Keratoplasty Neelofar Ghaznawi MD, Melissa B Daluvoy MD, Ajoy Virdi MD, Edwin S Chen, Kristin.
Role of HSV Infection in the Histopathology of Failed DSAEK
Anand K Shah MD1 Neda Shamie MD1 Paul Phillips MD1 Mark A Terry MD1,2*
Postoperative Complications Following Descemet-Stripping Automated Endothelial Keratoplasty in Patients with Prior Glaucoma Surgery Melissa B Daluvoy.
Francis Char DeCroos, MD
Presentation transcript:

Corneal graft survival and intraocular pressure control after Descemet stripping automated endothelial keratoplasty in eyes with pre-existing glaucoma Desmond QUEK1, Tina WONG1,2, Donald TAN1,2, Jodhbir MEHTA1,2,3 1Singapore National Eye Centre and Singapore Eye Research Institute 2Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore 3Clinical Sciences, Duke-NUS Graduate Medical School The authors have no financial interest in the subject matter of this e-poster Singapore National Eye Centre Singapore Eye Research Institute

Background DSAEK now the procedure of choice for endothelial dysfunction1-3 Reports on effect of DSAEK on IOP control and graft failure in eyes with pre-existing glaucoma limited Incidence of post-DSAEK IOP elevation 45%4 Graft failure rates higher in eyes with prior glaucoma filtration surgery or tube shunts5 Aim To describe the effect of DSAEK on IOP control and corneal graft survival in Asian eyes with pre-existing glaucoma or ocular hypertension 1. Koenig SB, Covert DJ. Early results of small-incision Descemet stripping and automated endothelial keratoplasty. Ophthalmology 2007;114(2):221-6. 2. Price MO, Price FW. Descemet stripping endothelial keratoplasty. Curr Opin Ophthalmol 2007;18(4):290-4. Bahar I, Kaiserman I, McAllum P, Slomovic A, Rootman D. Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty. Ophthalmology 2008;115(9):1525-33. Vajaranant TS, Price MO, Price FW, Gao W, Wilensky JT, Edward DP. Visual acuity and intraocular pressure after Descemet stripping endothelial keratoplasty in eyes with and without preexisting glaucoma. Ophthalmology 2009;116(9):1644-50. Letko E, Price DA, Lindoso EM, Price MO, Price FW, Jr. Secondary Graft Failure and Repeat Endothelial Keratoplasty after Descemet Stripping Automated Endothelial Keratoplasty. Ophthalmology 2010 Sep 22 [Epub ahead of print].

Methods Retrospective case series Inclusion criteria DSAEK Consecutive eyes with pre-existing glaucoma or OHT undergoing DSAEK Minimum follow-up duration of 12 months DSAEK By 5 surgeons Standard surgical technique Donor graft inserted via taco-folded or Sheets glide insertion technique Post-op prednisolone forte 1% q3H gradual taper Main outcome measures Graft failures Additional IOP lowering treatment post DSAEK

Variables examined Demographics Duration of f/u DSAEK indications Glaucoma diagnoses Duration of glaucoma Pre-DSAEK VA IOP Glaucoma treatment Additional intra-op procedures Phacoemulsification Synechiolysis ACIOL exchange Vitrectomy Post-DSAEK VA Mean post-op IOP Change in mean IOP IOP range

Results Value % Number of eyes, patients 47, 46 Age at DSAEK (mean ± SD) 66.6 ± 9.4 Gender (male), Race (Chinese) 24, 41 51.1, 87.2 Duration of follow-up, months 27.3 ± 8.5 Indications for DSAEK PBK with PCIOL PBK with ACIOL BK post LPI PBK with previous LPI Failed PK Fuchs endothelial dystrophy Posterior polymorphous dystrophy BK post glaucoma filtration surgery 11 4 3 5 1 23.4 8.5 6.4 10.6 2.1 Pre-DSAEK visual acuity 6/60 or worse 6/12 or better 32 1 68.1 2.1 Pre-DSAEK IOP (mmHg) 13.9 ± 4.3 Additional intraoperative procedures 16 34.0

Results Value % Pre-existing glaucoma diagnoses Acute primary angle closure Primary angle closure Primary angle closure suspect Primary angle closure glaucoma Primary open angle glaucoma Secondary angle closure glaucoma Secondary open angle glaucoma Ocular hypertension Angle closure Secondary glaucoma 2 4 5 7 3 6 18 24 4.3 8.5 10.6 14.9 6.4 12.8 38.3 51.1 Duration of glaucoma diagnosis (months) 75.4 ± 69.3 IOP lowering interventions pre-DSAEK LPI pre-DSAEK On at least 1 topical IOP medication No. of topical IOP medications Glaucoma filtration surgery pre-DSAEK Trabeculectomy Trabeculectomy with 5-FU Trabeculectomy with MMC Glaucoma drainage device Trabeculectomy + GDD 17 28 0.94 ± 0.96 14 5 1 6 36.2 59.6 29.8

Post DSAEK VA and IOP Results Value % Post DSAEK visual acuity Change in VA (Snellen lines) Improvement ≥ 2 Snellen lines Improvement < 2 Snellen lines Deprovement ≥ 2 Snellen lines VA of 6/12 or better at last follow-up Compared to pre DSAEK 5.4 ± 3.7 36 11 24 76.6 23.4 51.1 p<0.001 Post DSAEK IOP indices Post DSAEK mean IOP (mmHg) Lowest post DSAEK IOP (mmHg) Highest post DSAEK IOP (mmHg) Range of post-DSAEK IOP (mmHg) Change in IOP (mmHg) 16.0 ± 2.5 9.2 ± 2.6 27.4 ± 8.9 18.2 ± 9.6 2.1 ± 4.1 p=0.006

Graft failures Results Value % Number of DSAEK graft failures Number of repeat DSAEK Number of second DSAEK graft failures Interval to graft failure (months) 8 3 1 12.8 ± 7.0 17 37.5 33.3 Graft failure reasons Endothelial rejection Subsequent intra-ocular procedures Repositioning of IOL Trabeculectomy complicated by gross hyphaema Central graft-host dislocation Cytomegalovirus endothelitis 4 2 1 Control group No. of eyes undergoing DSAEK in the same time frame, by same surgeons, without pre-existing glaucoma No. of graft failures Compared to eyes with glaucoma 137 11 8 p=0.08

Kaplan-Meier curve for graft survival KM estimated probability of graft survival at 1 year = 100% 2 years = 94.2% Risk factors for graft failure None identified

IOP treatment post DSAEK Results Value % On at least 1 topical medication post DSAEK Compared to pre DSAEK Requiring fewer topical medications post DSAEK Requiring additional IOP lowering treatment Requiring additional topical medication(s) only Requiring glaucoma filtration surgery only Requiring additional medication(s) and surgery Interval from DSAEK and glaucoma surgery (months) No. of topical medications post DSAEK No. of additional topical medications post DSAEK 36 3 29 21 2 6 9.3 ± 6.9 2.0 ± 1.5 1.1 ± 1.4 74.5 p=0.05 6.4 61.7 72.4 6.9 20.7 p<0.001 Risk factors for need for additional IOP lowering treatment No pre DSAEK glaucoma filtration surgery Odds ratio = 10.8, p = 0.002 (univariate) Additional intra-operative procedures during DSAEK Odds ratio = 18.2, p = 0.008 (univariate) Odds ratio = 12.2, p = 0.033 (multivariate)

Discussion Eyes that had undergone glaucoma surgery pre-DSAEK were less likely to require additional IOP lowering treatment post-DSAEK Suggests that pre-DSAEK glaucoma filtration surgery is able to adequately control post-DSAEK IOP elevations in majority of eyes Eyes that underwent additional intraoperative procedures during DSAEK were more likely to require additional IOP-lowering therapy post-DSAEK Additional procedures presumably incited additional post-operative inflammation, or caused further direct damage to the trabecular meshwork, leading to post-DSAEK IOP rise Monitoring of glaucoma progression remains a challenge in eyes with corneal decompensation secondary to endothelial dysfunction Perimetry results pre-DSAEK are seldom reliable nor accurate Optic disc is often not clearly visualized Angle assessment hindered by peripheral corneal opacification In our study, mean highest IOPs of 27.4 ± 8.9 and a wide range of IOP fluctuation of 18.2 ± 9.6 mm Hg were observed post-DSAEK However, the mean rise in IOP post-DSAEK was modest, with an overall mean increase of 2 mm Hg Prompt and efficient lowering of raised IOP post-DSAEK could explain for the overall low rise in IOP Efforts should be made to reduce raised IOP in post-DSAEK glaucomatous eyes, to prevent progression of glaucomatous optic nerve damage

LIMITATIONS CONCLUSIONS Retrospective Small sample size Lack of control group Non-standardization of glaucoma treatment protocols Further prospective randomized controlled studies will be required to better elucidate True effect on intraocular pressure control Glaucoma progression CONCLUSIONS With prompt and appropriate intervention, IOP in glaucomatous eyes undergoing DSAEK can be controlled with minimal increase post-DSAEK Glaucomatous eyes without prior filtration surgery and eyes that underwent additional intraoperative procedures during DSAEK are more likely to require additional IOP-lowering therapy These eyes should be carefully monitored, and IOP-lowering therapy promptly instituted to prevent possible progression of glaucoma